Advertisement

Picture Berlin Partner BIO 2024 International Convention San Diego 650x100px
Organisation › Details

BioGenCell Ltd.

TRACT (Tissue Regenerative Activated Cell Therapy) is the only technology that provides safe and efficient specialized cells within a day in every clinic while being both patient and clinician friendly. BioGenCell was founded with the vision of developing safe, effective, and long-lasting effective treatment for incurable, blood vessel diseases that will be both accessible and patient friendly. Our disruptive TRACT technology platform provides a comprehensive approach for rapid manufacturing and commercialization of cell-therapies. Who are we? BioGenCell is a clinical stage company providing treatment for incurable patients suffering from life threatening degenerative diseases. Our multinational company is led by multidisciplinary key opinion leaders creating together economic, therapeutic solutions based on fast-track commercialization programs. What do we do? BioGenCell brings you the new era of Personalized Stem Cell Therapy in every clinic worldwide via a simple standard blood draw. Our proprietary technology TRACT (Tissue Regenerative Activated Cell Therapy) is based on an unprecedented combination of the power of immunology and stem cell therapy providing personalized regenerative treatment for damaged tissues. How do we do it? We make it simple! A nurse takes a standard blood draw from your arm and you are called the following day to receive the treatment by your doctor. No need for any pre-treatment, sophisticated machinery or operations. BioGenCell’s products are manufactured from blood cells selected and cultured to create specific therapeutic cells provided to clinicians in ready to use syringes. TRACT is the only technology that provides lineage specific cells in a rapid process that takes less than one day. *

 

Period Start 2022-05-09 existent
Products Industry TRACT technology (Tissue Regenerative Activated Cell Therapy)
  Industry 2 cell therapy
Persons Person Porat, Yael (BioGenCell 202205 CEO + Co-Founder)
  Person 2 Nacht, Marius (aMoon 201701 Co-Founder plus Co-Founder + Chairman of Check Point Software Technologies)
     
Region Region Netanya
  Country Israel
  Street 16 Divrey Chaim Street
  City 4244916 Netanya
  Tel +972-9-860-9598
    Address record changed: 2022-07-14
     
Basic data Employees n. a.
     
    �About Section� taken from web site of organisation on 10.07.
     
   
Record changed: 2023-07-10

Advertisement

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for BioGenCell Ltd.


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group World of Partnering Opportunities 650x300px




» top